Chronic Myeloid Leukemia: A Review

Chronic myeloid leukemia is a myeloproliferative neoplasm that affects approximately 5 million people worldwide. Tyrosine kinase inhibitors, such as imatinib, have substantially improved survival in patients with chronic myeloid leukemia. In this podcast, author Elias J. Jabbour, MD, of the University of Texas MD Anderson Cancer Center, discusses diagnosis and treatment of chronic myeloid leukemia with JAMA Deputy Editor Mary McDermott, MD. Related Content: Chronic Myeloid Leukemia

Episode metadata supplied by the publisher feed · Published Mar 17, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Chronic Myeloid Leukemia: A Review

0:00 17:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 17 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on March 17, 2025.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!